Galanin receptors in GtoPdb v.2021.3 by Gundlach, Andrew L. & Ryan, Philip J.
IUPHAR/BPS	Guide	to	Pharmacology	CITE
https://doi.org/10.2218/gtopdb/F27/2021.3
Galanin	receptors	in	GtoPdb	v.2021.3
Andrew	L.	Gundlach1	and	Philip	J.	Ryan1
1.	 University	of	Melbourne,	Australia
Abstract
Galanin	receptors	(provisional	nomenclature	as	recommended	by	NC-IUPHAR	[57])	are
activated	by	the	endogenous	peptides	galanin	and	galanin-like	peptide.	Human	galanin	is	a	30	amino-
acid	non-amidated	peptide	[52];	in	other	species,	it	is	29	amino	acids	long	and	C-terminally	amidated.
Amino	acids	1-14	of	galanin	are	highly	conserved	in	mammals,	birds,	reptiles,	amphibia	and	fish.
Shorter	peptide	species	(e.g.	human	galanin-1-19	[21]	and	porcine	galanin-5-29	[170])	and	N-
terminally	extended	forms	(e.g.	N-terminally	seven	and	nine	residue	elongated	forms	of	porcine
galanin	[22,	170])	have	been	reported.	More	recently,	the	newly-identified	peptide,	spexin	(SPX),	has
been	reported	to	activate	human	GAL2	and	GAL3	(but	not	GAL1)	receptors	in	heterologous
expression	systems;	and	to	alter	GAL2/3	receptor-related	behaviours	in	animals	[89].
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This	is	a	citation	summary	for	Galanin	receptors	in	the	Guide	to	Pharmacology	database	(GtoPdb).	It
exists	purely	as	an	adjunct	to	the	database	to	facilitate	the	recognition	of	citations	to	and	from	the
database	by	citation	analyzers.	Readers	will	almost	certainly	want	to	visit	the	relevant	sections	of	the
database	which	are	given	here	under	database	links.
GtoPdb	is	an	expert-driven	guide	to	pharmacological	targets	and	the	substances	that	act	on	them.
GtoPdb	is	a	reference	work	which	is	most	usefully	represented	as	an	on-line	database.	As	in	any
publication	this	work	should	be	appropriately	cited,	and	the	papers	it	cites	should	also	be	recognized.
This	document	provides	a	citation	for	the	relevant	parts	of	the	database,	and	also	provides	a
reference	list	for	the	research	cited	by	those	parts.	For	further	details	see	[31].
Please	note	that	the	database	version	for	the	citations	given	in	GtoPdb	are	to	the	most	recent
preceding	version	in	which	the	family	or	its	subfamilies	and	targets	were	substantially	changed.	The
links	below	are	to	the	current	version.	If	you	need	to	consult	the	cited	version,	rather	than	the	most
recent	version,	please	contact	the	GtoPdb	curators.
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